[
  {
    "ts": null,
    "headline": "Are You Looking for a Top Momentum Pick? Why Cardinal Health (CAH) is a Great Choice",
    "summary": "Does Cardinal Health (CAH) have what it takes to be a top stock pick for momentum investors? Let's find out.",
    "url": "https://finnhub.io/api/news?id=a54f97fc36a3bd2dda92e701f98b8c879ca73cff6822ffdd34d03155d1d48a8c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1762794003,
      "headline": "Are You Looking for a Top Momentum Pick? Why Cardinal Health (CAH) is a Great Choice",
      "id": 137396793,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CAH",
      "source": "Yahoo",
      "summary": "Does Cardinal Health (CAH) have what it takes to be a top stock pick for momentum investors? Let's find out.",
      "url": "https://finnhub.io/api/news?id=a54f97fc36a3bd2dda92e701f98b8c879ca73cff6822ffdd34d03155d1d48a8c"
    }
  },
  {
    "ts": null,
    "headline": "Biopsy Devices Market: Key Players Analysis Recent Developments, Company Strategies, Sustainability Benchmarking, Product Launches, Key Persons, and Revenue Forecasts",
    "summary": "The Biopsy Devices market is projected to reach $4.02 billion by 2033, growing from $2.43 billion in 2024 at a CAGR of 5.75%. This growth is driven by personalized care demand, rising cancer cases, and minimally invasive treatments enhancing patient comfort. Key biopsy devices include needle, punch, and surgical tools for various medical needs. Advancements in biopsy technology ensure precise, early cancer detection and improved patient outcomes. Leading companies like Cardinal Health, Hologic,",
    "url": "https://finnhub.io/api/news?id=327b66287fb9b94011c8a210cc9102372ceccbbc561cab2c90573aa89a0961a7",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1762784220,
      "headline": "Biopsy Devices Market: Key Players Analysis Recent Developments, Company Strategies, Sustainability Benchmarking, Product Launches, Key Persons, and Revenue Forecasts",
      "id": 137395059,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CAH",
      "source": "Yahoo",
      "summary": "The Biopsy Devices market is projected to reach $4.02 billion by 2033, growing from $2.43 billion in 2024 at a CAGR of 5.75%. This growth is driven by personalized care demand, rising cancer cases, and minimally invasive treatments enhancing patient comfort. Key biopsy devices include needle, punch, and surgical tools for various medical needs. Advancements in biopsy technology ensure precise, early cancer detection and improved patient outcomes. Leading companies like Cardinal Health, Hologic,",
      "url": "https://finnhub.io/api/news?id=327b66287fb9b94011c8a210cc9102372ceccbbc561cab2c90573aa89a0961a7"
    }
  }
]